Polling the U.S. public on booster shots; seniors face hurdles to getting high-cost medicines

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: STAT-Harris Poll: Most Americans would get a Covid-19 booster shot if recommended By Ed Silverman Eugene Hoshiko/AP A new poll of U.S. adults finds six in 10 have already decided they will get a booster if it's recommended for them. Read More STAT+: Many Medicare Part D beneficiaries don't fill prescriptions for high-priced medicines By Ed Silverman Charlie Neibergall/AP Part D beneficiaries who have low incomes and receive subsidies were nearly twice as likely to fill a prescription as those without subsidies. Read More Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters By Andrew Joseph and Matthew Herper JOEL SAGET/AFP via Getty Images STAT will be live-blogging the all-day meeting of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC. Read More Sponsor content by STAT TRIALS PULSE How a biotech startup is using AI tools to redefine how they approach clinical development Artificial Intelligence is transforming the way small biotechs are scaling their businesses. In our latest case study of Feldan Therapeutics, we show how STAT Trials Pulse has become a game-changer for them, helping accelerate data-gathering, better analyze their competitors, and streamline their operations. Read the case. Opinion: STAT+: Reimagining R&D can cut drug development costs from billions to millions By Nicole Paraggio and Nicole van Poppel and Selen Karaca-Griffin Abobe Transforming R&D has a pivotal role to play in exponentially reducing the cost of discovering and developing new drugs. Read More Wednesday, April 6, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser